GENB insider transactions
Generate Biomedicines Inc. (GENB) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
GENB insiders
Everyone who has filed a Form 3, 4, 5 or 144 at Generate Biomedicines Inc., latest first. Follow anyone to get their next filing.
- Frances ArnoldDirector-$201K
- Pioneering Medicines 02, LLC10% owner, since March 2026
- Michael NallyChief Executive Officer, Director+$240K
- Rupert VesseyDirector
- Beth GrousChief People Officer+$4,800
- Laurie Anne LeeChief Medical Officer
- Sean MartinChief Legal Officer & GC
- Nancy A SimonianDirector
- Jason SilversPresident & CFO+$32K
- Noubar AfeyanDirector, 10% owner+$150M
- Gevorg GrigoryanChief Technology Officer
- Stephane BancelDirector
- Jane L MendilloDirector+$24K
- Marsha FanucciDirector
- Paul Gray ParkerDirector
Recent Form 3, 4, and 5 filings for GENB
- Director Arnold Frances sold $184,733 worth of shares (11,409 units at $16.19) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 220,063 units (SEC Form 4)4 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- Director Arnold Frances sold $16,002 worth of shares (1,000 units at $16.00) as part of a pre-agreed trading plan, decreasing direct ownership by 0.43% to 231,472 units (SEC Form 4)4 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- New insider Pioneering Medicines 02, Llc claimed ownership of 1,562,500 shares (SEC Form 3)3 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- Chief Executive Officer Nally Michael bought $240,000 worth of shares (20,000 units at $12.00), increasing direct ownership by 4% to 572,707 units (SEC Form 4)4 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- SEC Form 4 filed by Director Vessey Rupert4 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- Chief People Officer Grous Beth bought $4,800 worth of shares (300 units at $16.00) (SEC Form 4)4 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- SEC Form 4 filed by Director Arnold Frances4 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- SEC Form 4 filed by Chief Legal Officer & GC Martin Sean4 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Lee Laurie Anne4 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- SEC Form 4 filed by Director Simonian Nancy A4 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- President & CFO Silvers Jason bought $32,000 worth of shares (2,000 units at $16.00) (SEC Form 4)4 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- Director Afeyan Noubar converted options into 32,969,159 shares and bought $75,000,000 worth of shares (4,687,500 units at $16.00) (SEC Form 4)4 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- SEC Form 4 filed by Chief Technology Officer Grigoryan Gevorg4 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- Chief Executive Officer Nally Michael converted options into 658,327 shares (SEC Form 4)4 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- Director Bancel Stephane converted options into 724,160 shares (SEC Form 4)4 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- Director Mendillo Jane L bought $24,000 worth of shares (1,500 units at $16.00) (SEC Form 4)4 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- SEC Form 4 filed by Director Fanucci Marsha4 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- SEC Form 4 filed by Director Parker Paul Gray4 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- Director Afeyan Noubar converted options into 32,969,159 shares and bought $75,000,000 worth of shares (4,687,500 units at $16.00) (SEC Form 4)4 - Generate Biomedicines, Inc. (0002100782) (Issuer)